Fairmark Insights

HCP Fair Market Value (FMV) and HCP Tiering

Fairmark Insights provides perspectives on HCP Fair Market Value (FMV), including rate setting, tiering, and documentation practices for pharmaceutical, biotech, and medical device companies. These articles reflect Fairmark’s approach to FMV, grounded in objective measures of healthcare professional expertise and earnings.

Across these perspectives, we examine how HCP FMV is determined, the limitations of commonly used approaches, and the structural considerations that influence rate setting decisions for HCP speaking and consulting services.

This includes both foundational issues, such as the role of FMV benchmarking and the use of objective measures of HCP expertise, and practical considerations that arise in contracting, documentation, and tiering.

Foundational Perspectives

Foundational perspectives outline how Fairmark approaches HCP FMV, including the principles used to evaluate compensation and the limitations of commonly used industry methods.

A Framework for Fair Market Value in HCP Engagements

Conceptual analysis (Fairmark)
Examines how HCP Fair market Value (FMV) is established in manufacturer–physician speaking and consulting arrangements, focusing on arm’s-length standards, limitations of industry-derived payment data, and grounding compensation in independent physician earnings. The analysis also addresses the distinction between time-based compensation and perceived value to the company, the role of tiering in supporting differentiated FMV rates, and the risk of undetected overpayment. Review Article

Why Industry Benchmarking Is Not Appropriate For Determining FMV

Conceptual analysis (Fairmark)
Explains why industry benchmarking of HCP FMV rates introduces structural distortion into FMV rate setting by relying on data shaped by the same physician–industry relationships it is meant to evaluate. Presents an alternative methodology grounded in independent physician compensation data that is more stable, objective, and defensible under regulatory scrutiny. Review Article

Practical Considerations

Practical considerations address how FMV is applied in real-world HCP engagement, including contracting decisions, documentation, and areas of potential compliance risk.

Why FMV Overpayment Persists Even in Strong Compliance Programs

Examines why overpayment risk in HCP engagements can persist despite well-designed compliance frameworks. The analysis focuses on how common FMV inputs, including historical rates, benchmarking, and vendor-influenced pricing, can embed structural bias that is difficult to detect. It highlights why FMV overpayment often develops gradually and remains hidden within otherwise consistent and well-documented fee schedules. Review Article

FMV Exceptions: Misconceptions and Practical Considerations

Clarifies common misconceptions about FMV exceptions and explains how they should be evaluated within a structured compliance framework. Emphasizes that exceptions do not permit payments above fair market value and outlines the key questions and documentation standards required to support defensible decisions. Provides a practical approach to managing HCP FMV exception requests while maintaining an arm’s-length standard. Review Article

Publications & Industry Contributions

This section highlights Fairmark’s externally published work on fair market value (FMV) methodology and HCP FMV tiering. These publications reflect peer-reviewed and industry-recognized perspectives on how FMV is determined in practice, particularly in the context of HCP speaking and consulting services.

Fair Market Value Methodology in Physician Consulting Arrangements

Peer-reviewed legal publication (FDLI Journal)
Examines how HCP FMV is determined in manufacturer–physician consulting arrangements, including the limitations of commonly used data sources and the importance of grounding compensation in objective physician earnings. The analysis focuses on how HCP FMV is evaluated under regulatory scrutiny, with emphasis on methodology, consistency, and documentation. Review Article

Determining KOL Status for FMV Purposes

Industry publication (RX Compliance Report)
Evaluates commonly used HCP FMV tiering frameworks for determining KOL status, and identifies structural limitations that can lead to over-tiering and unsupported premium compensation. The analysis distinguishes between indicators of expertise and company-driven selection factors, emphasizing the role of objective, peer-recognized achievement in supporting FMV differentiation. Review Article